pyridinolcarbamate has been researched along with Diabetes Mellitus in 2 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Semichastnova, AG | 1 |
| Golubiatnikova, GA | 1 |
| Permiakov, NK | 1 |
| Titova, GP | 1 |
| Bokaneva, IA | 1 |
| Notarbartolo, A | 1 |
| Rini, GB | 1 |
| Di Fede, G | 1 |
2 other studies available for pyridinolcarbamate and Diabetes Mellitus
| Article | Year |
|---|---|
[Effect of anginine on the state of the stomach and pancreas in diabetes mellitus].
Topics: Adolescent; Adult; Aged; Capillaries; Carbamates; Diabetes Mellitus; Gastric Mucosa; Humans; Middle | 1975 |
[Changes of the electrophoretic tracing of the serum glycoproteins in diabetic subjects treated with pyridinolcarbamate].
Topics: Adult; Aged; Carbamates; Diabetes Mellitus; Female; Glycoproteins; Humans; Male; Middle Aged; Pyridi | 1973 |